News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UCB's U.S. Zyrtec Sales Up Two Percent At $299 Millon


10/19/2005 5:10:57 PM

First-quarter U.S. sales of UCB's (UCBBt.BR: Quote, Profile, Research) Zyrtec anti-hayfever drug rose two percent to $299 million, Zyrtec's U.S. distributor Pfizer (PFE.N: Quote, Profile, Research) said on Tuesday, a result at the low end of analysts' expectations.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES